SPOTLIGHT -
Updated Key to the Diagnosis of Dementia
Alzheimer disease-or dementia with Lewy bodies? Recently revised consensus criteria can help you solve this diagnostic dilemma.
Key to Prevention of Cognitive Decline in Hypertensive Patients
Although high blood pressure may put patients at risk for dementia, a class of antihypertensives appears to have a preventive effect.
Alzheimer Prevention: The Skinny on Genes and Fats
The genetics of dementia, dyslipidemia, and diabetes may hold the key to preventive therapy.
A Weapon Against Dementia in Your Coffeepot
The caffeine in your morning cup of java could pack a neuroprotective punch.
Aerobic Exercise for the Older Brain
Can cardiovascular fitness help older adults ward off dementia?
PET Shines Light on Early-Stage Alzheimer Disease
The goal of clinically relevant detection of neuropathological hallmarks may be in sight.
Do Patients Want to Know Whether Alzheimer Disease Awaits Them?
Older adults seem willing to take a hypothetical predictive test-and plan accordingly.
Risk Factors for Recurrent MDD in Midlife Women
Are you aware of 2 newly identified predictors of a pernicious depression course in middle-aged women?
A Cautious Thumbs-Up for St. John’s Wort
Is St. John’s wort (SJW; Hypericum perforatum) an appropriate treatment option for patients with MDD? What advice should be given to patients who inquire about it?
TMS Versus ECT: That Is the Question
Among patients with treatment-resistant MDD, transcranial magnetic stimulation wins the popular vote.
Ten-Year Trend Shows Improved Care for Low-Income ADHD Patients
Rising costs and changing treatment trends have sparked concerns about quality of care.
SSRIs Target Psychological But Not Somatic Symptoms in MDD
Recent studies illustrate the importance of homing in on the somatic symptoms of depression
Self-Monitoring Program for MDD Lacks Human Touch
Which patients are most likely to find a computer-based program helpful?
Potential MDD Biomarkers May Lead to Objective Diagnosis
A safe, noninvasive method for early detection of depression could be around the corner.
BPA Plastics Linked to ADHD in Boys
Have these researchers found a smoking gun?
CBT Boosts Mood But What About Neuropsychological Functioning?
How best to tackle a challenging core feature of MDD.
Value of Methylphenidate for ADHD Called Into Question
How strong is the foundation of current pharmacotherapy recommendations for ADHD?
Jury Is Out on Omega-3 for Major Depression
Here: Insights regarding both the potential positive and negative effects of omega-3 fatty acids on depressive symptoms.
Accurate Diagnosis of ADHD in the Absence of Teacher Reports
How to make a DSM-IV–compliant diagnosis when the child’s behavior in school cannot be assessed.
Sexual Dysfunction, SSRIs, and Depression
Improvement in depressive symptoms appears to have a salutary effect on sexual function.
Guanfacine Improves Function as Well as ADHD Symptoms
Encouraging results from one of the few clinical trials that focus on function in ADHD.
White Noise Benefits Kids With ADHD
This nondrug intervention may enhance cognition in children with ADHD.
ECT May Enhance Neuroplasticity in Treatment of Acute MDD
ECT has been an acute intervention for patients with severe resistant MDD, but what is its effect on brain volume?
Novel Route for Ketamine in the Treatment of MDD
This method of administration can mitigate the psychotomimetic and dissociative effects of ketamine.
Drugs vs Psychotherapy for MDD: Patient’s Choice?
A new finding that may help optimize the treatment of major depressive disorder.
Study Shines a Light on Depression
Researchers conducted a clinical trial comparing light therapy with antidepressant monotherapy. Here's what they found.
Bioequivalence for Generic ADHD Medications
When it comes to treating ADHD, not all medications are alike.
Benzodiazepine Use in MDD
Intended for short-term use, this treatment is associated with specific diagnostic and symptom characteristics, with anhedonia being a stand-out.
Is TMS Cost-Effective?
Researchers looked into the efficacy and value of TMS for treatment-resistant depression.
Face-Reading Reveals Schizophrenia Risk
Deficits in emotion recognition among at-risk patients may predict eventual transition to schizophrenia.